疏血通注射液治疗急性脑梗死59例

目的:评价疏血通治疗急性脑梗死(ACI)的临床疗效.方法:118例急性脑梗死患者随机分成治疗组和对照组.治疗组用疏血通注射液6 mL每日1次静脉滴注,15 d为1个疗程；采用通常的治疗方案,给予低分子右旋糖酐静滴,口服肠溶阿司匹林100 mg·d-1,有脑水肿给予20％甘露醇脱水等常规治疗.评价治疗前和治疗后的神经功能缺损评分.结果:治疗组与对照组比较,神经功能缺损评分改善显著(P＜0.01),治疗组显效率高于对照组(P＜0.01).结论:疏血通注射液治疗急性脑梗死比常规治疗效果好,并且安全、简便和可靠.

Clinical Observation on Shuxuetong Injection in Treatment of Patients with Acute Cerebral Infarction

Objective: To evaluate efficacy of Shuxuetong injection in treatment of patients with acute cerebral infarction. Method: One hundred and eighteen patients with acute cerebral infarction(ACI) were randomly divided into therapy group and control group.Therapy group was given Shuxuetong injection 6 mL by Intravenous infusion for 15 day,control group was given conventional therapy method.Neurologic defect scoring at admission and after treatment was performed. Result: Compared with control group. neurologic defect scoring in therapy group was improved significantly (P<0.01),the effectivet rate was higher than that in control group(P<0.01). Conclusion: Shuxuetong injection in treatment of patients with acute cerebral infarction has more significant effect, and the treatment is safe.